In 2004, it was demonstrated that changes in female reproductive tissue due to insemination result in immunological priming to paternal antigens and influence pregnancy outcome. During mating, exposure to seminal fluid elicits a tolerant state to paternal allo-antigens by expanding the regulatory T cell (Treg) pool. Notably, mating with males with surgically removed seminal vesicle glands was shown to fail to induce such effects.
1 Evidence of antigen-specific Treg responses [2] [3] [4] suggested that the expansion of the Treg pool occurs in response to seminal vesicle fluid. 6 Further research has revealed differential recruitment of Tregs into different tissues, including the liver, kidney, heart, spleen, lymph nodes, mucosal tissues, blood, skin, thymus and brain, of which recruitment to the brain was the lowest.
1 Owing to these effects on Treg expansion and the lower recruitment to the brain, we administered seminal vesicle fluid via an intra-cerebrospinal fluid (CSF) route in a Lewis rat model of experimental autoimmune encephalomyelitis (EAE) and investigated its effect on Treg expansion and clinical disease course. We induced EAE in Lewis rats and treated them with saline, 0.1 mg/ml chymotrypsin or seminal vesicle fluid (liquefied using chymotrypsin). Then, IFN-c, IL-4, IL-17 and FoxP3 expression were estimated using a two-step real-time PCR method on samples from the brain, spinal cord and deep cervical lymph node (Supplementary Information). Our EAE Lewis rat model exhibited an acute monophasic disease, with clinical signs beginning on day 7 and reached the peak of the disease on day 14 post-induction. Intra-CSF injection of seminal vesicle fluid, 0.1 mg/ml chymotrypsin or saline was performed on day 7 after EAE induction. Changing trends in clinical signs in seminal vesicle fluid-treated animals were markedly different from those in the animals treated with 0.1 mg/ml chymotrypsin or saline (Figure 1a ). The maximum mean clinical scores during the course of study were 1.46, 1.41 and 0.41, in saline-, 0.1 mg/ml chymotrypsin-and seminal vesicle fluid-treated animals, respectively.
Changes in EAE-associated gene expression were estimated during the peak of the disease (day 14 after EAE immunization). Because EAE is a T cell-mediated disease, we investigated the changes in IFN-c, IL-4 , IL-17, and FoxP3 expression as representatives of Th1, Th2, Th17, and Treg, respectively ( Figure 1b) .
Seminal vesicle fluid administration resulted in a significant decreased in IFN-c expression in the brain compared with saline-treated animals. In addition, IFN-c expression was significantly decreased in animals treated with 0.1 mg/ml chymotrypsin compared with saline-and seminal vesicle fluidtreated animals. IL-17 expression was also determined because it is a critical cytokine in EAE. Injecting animals with seminal vesicle fluid significantly downregulated IL-17 expression compared with the saline-and 0.1 mg/ml chymotrypsin-treated animals. In contrast, IL-17 expression in the 0.1 mg/ml chymotrypsin-treated animals was markedly increased compared with in saline-treated animals. To further explore the mechanism of the decreased clinical score upon seminal vesicle fluid treatment, the expression of IL-4 and FoxP3 was investigated. 5, 6 FoxP3 is indicative of naturally occurring Tregs which have an anti-inflammatory effect.
5 IL-4 is also indicative of the Th2 response and exhibits an ameliorating effect on EAE.
6 No significant differences were observed in IL-4 expression between the groups treated with saline, 0.1 mg/ml chymotrypsin, or seminal vesicle fluid. Regarding FoxP3, significant upregulation of FoxP3 expression was observed in the seminal vesicle fluid-treated animals compared with the 0.1 mg/ml chymotrypsin-and saline-treated animals, suggesting Treg upregulation upon seminal vesicle fluid treatment. No significant differences in FoxP3 expression were observed between the groups of animals treated with 0.1 mg/ml chymotrypsin or saline.
The seminal vesicle fluid-and 0.1 mg/ml chymotrypsintreated rats exhibited a significant decrease in IFN-c expression in the spinal cord compared with the saline-treated animals. However, IFN-c levels in the seminal vesicle fluid-treated animals were significantly higher than those of the 0.1 mg/ml chymotrypsin-treated animals. Seminal vesicle fluid treatment markedly attenuated IL-17 expression compared with the 0.1 mg/ ml chymotrypsin-and saline-treated animals. However, no significant differences were observed between the saline-and 0.1 mg/ ml chymotrypsin-treated animals in terms of IL-17 expression. The levels of IL-4, a Th2 cytokine, in the seminal vesicle fluid-and 0.1 mg/ml chymotrypsin-treated animals were similar to those in the saline-treated group. FoxP3 expression was significantly elevated only in the animals treated with seminal vesicle fluid compared with the saline-and 0.1 mg/ml chymotrypsintreated animals. However, FoxP3 expression was not significantly different between the 0.1 mg/ml chymotrypsin-and salinetreated animals. Seminal vesicle fluid treatment resulted in significant suppression of IFN-c expression in the DCLNs (drainage lymph nodes of central nervous system 7 ) compared with saline and 0.1 mg/ml chymotrypsin treatment. In addition, IL-17 mRNA levels were significantly decreased in the DCLNs of the seminal vesicle fluid-treated animals compared with the saline-and 0.1 mg/ml chymotrypsin-treated animals. Additionally, IL-17 expression was significantly stimulated in the 0.1 mg/ml chymotrypsin-treated animals compared with the saline-treated group. In contrast, IL-4 expression was significantly increased upon treatment with seminal vesicle fluid or 0.1 mg/ml chymotrypsin compared with saline treatment. Treatment with 0.1 mg/ml chymotrypsin resulted in significant stimulation of IL-4 expression compared with treatment with seminal vesicle fluid. A significant increase in FoxP3 mRNA levels upon seminal vesicle fluid treatment was observed compared with saline or 0.1 mg/ml chymotrypsin treatment. No significant differences in FoxP3 mRNA levels were observed between the saline-and 0.1 mg/ml chymotrypsin-treated animals.
Our results suggest that seminal vesicle fluid contains all of the ligands required to activate the natural Treg pool and has anti-inflammatory effects in organs outside the reproductive system. Seminal vesicle fluid can increase Treg numbers in the central nervous system, specifically at the inflammatory foci (i.e., the spinal cord), and these effects are accompanied by a decrease in clinical signs. Our observations are consistent with the unexplained preferential targeting of inflammation to the spinal cord in EAE. 8 The Treg expansion in response to seminal vesicle fluid appears to be affected by a distal effect, as observed in the brain during mating.
1 Presumably, local seminal vesicle fluid administration by intra-CSF injection can ameliorate this distal effect, as observed in this study. Interestingly, seminal vesicle fluid from male rats more than 410 g (about 3-4 months of age) exhibited this healing effect. However, seminal vesicle fluid obtained from younger rats did not exhibit this effect on Treg expansion. Seminal vesicle fluid administration seems to cause a 'pseudo-mating state' in the target organ.
This study was performed at the gene expression level and represents the initial step in developing a hypothesis regarding the action of seminal vesicle fluid in the central nervous system and organs outside the female reproductive system. Further optimization of the route, dose and regimen of administration may improve the beneficial effect of seminal vesicle fluid.
